Shinichi Tamura - Sosei Group CEO
| SOLTF Stock | USD 8.05 0.00 0.00% |
CEO
Mr. Shinichi Tamura was named Chairman of the Executive Board, President, Representative Executive Officer and Chief Executive Officer in Sosei Group Corporation effective January 1, 2019. He is also a member of Nominating Committee in the Company. He used to work for a company that is under the new name of Astellas Pharma Inc. and Genentech, Inc., and also served as President and Representative Director in a subsidiary and another company since 2019.
| Age | 74 |
| Tenure | 5 years |
| Phone | 81 3 5210 3290 |
| Web | https://soseiheptares.com |
Sosei Group Management Efficiency
The company has return on total asset (ROA) of 0.0714 % which means that it generated a profit of $0.0714 on every $100 spent on assets. This is way below average. Sosei Group's management efficiency ratios could be used to measure how well Sosei Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CEO Age | ||
| Marc Voigt | Immutep Ltd ADR | 51 | |
| Daniel Paterson | Verastem | 63 | |
| Raul Rodriguez | Rigel Pharmaceuticals | 63 | |
Management Performance
| Return On Equity | -0.007 | |||
| Return On Asset | 0.0714 |
Sosei Group Leadership Team
Elected by the shareholders, the Sosei Group's board of directors comprises two types of representatives: Sosei Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sosei. The board's role is to monitor Sosei Group's management team and ensure that shareholders' interests are well served. Sosei Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sosei Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Candelle Chong, VP Communications | ||
| Chris Cargill, President, Officer | ||
| Stacey Southall, Associate Biophysics | ||
| Shinichiro Nishishita, VP Disclosures | ||
| Shinichi Tamura, CEO and President Representative Executive Officer, Director and Member of Nomination Committee | ||
| Kieran FCA, VP Officer | ||
| Miles Congreve, Chief Officer | ||
| Kazuhiko Yoshizumi, VP Officer | ||
| Hironoshin Nomura, VP Relations | ||
| Barry Kenny, Chief Devel |
Sosei Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sosei Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.007 | |||
| Return On Asset | 0.0714 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.46 % | |||
| Current Valuation | 958.29 M | |||
| Shares Outstanding | 81.92 M | |||
| Shares Owned By Insiders | 12.05 % | |||
| Shares Owned By Institutions | 26.29 % | |||
| Price To Earning | 66.82 X | |||
| Price To Book | 2.36 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sosei Pink Sheet
Sosei Group financial ratios help investors to determine whether Sosei Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sosei with respect to the benefits of owning Sosei Group security.